Integrated network toxicology and transcriptomics uncover that the involvement of NF-κB/NLRP3 pyroptosis axis in mediating BaP-induced hepatotoxicity and fibrosis
Bohe Wang, Xiuxia Dong, Jiayue Li, Xiaojuan Feng, Yongkang Chen, Na Liu, Pengjuan Fu, Junling Wang, Xiangli Li
{"title":"Integrated network toxicology and transcriptomics uncover that the involvement of NF-κB/NLRP3 pyroptosis axis in mediating BaP-induced hepatotoxicity and fibrosis","authors":"Bohe Wang, Xiuxia Dong, Jiayue Li, Xiaojuan Feng, Yongkang Chen, Na Liu, Pengjuan Fu, Junling Wang, Xiangli Li","doi":"10.1016/j.etap.2026.105179","DOIUrl":null,"url":null,"abstract":"<div><div>Benzo[<em>a</em>]pyrene (BaP), a ubiquitous environmental pollutant, exerts hepatotoxicity primarily through its metabolite BPDE. This study combined network toxicology and experimental validation to delineate the mechanisms of BaP-induced liver injury and fibrosis. Network analysis identified ICAM-1 as a potential core target, and previous clinical data confirmed its upregulation in liver injury patients. In a rat model, BaP exposure induced dose-dependent hepatic injury and oxidative stress. Mechanistically, BaP activated the NF-κB/TNF-α signaling axis, upregulating ICAM-1 and initiating NLRP3 inflammasome assembly. Activated NLRP3 promoted Caspase-1-dependent cleavage of GSDMD, leading to hepatocyte pyroptosis and the release of IL-1β and IL-18. Concurrently, ICAM-1 facilitated inflammatory cell infiltration. This sustained inflammatory microenvironment ultimately activated the TGF-β/α-SMA/Col-I axis, driving hepatic stellate cell activation and excessive extracellular matrix deposition, thereby promoting liver fibrosis. Our findings elucidate a cascading pathway linking BaP exposure to oxidative stress, NLRP3-mediated pyroptosis, and hepatic fibrogenesis.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"127 ","pages":"Article 105179"},"PeriodicalIF":4.6000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668926002577","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Benzo[a]pyrene (BaP), a ubiquitous environmental pollutant, exerts hepatotoxicity primarily through its metabolite BPDE. This study combined network toxicology and experimental validation to delineate the mechanisms of BaP-induced liver injury and fibrosis. Network analysis identified ICAM-1 as a potential core target, and previous clinical data confirmed its upregulation in liver injury patients. In a rat model, BaP exposure induced dose-dependent hepatic injury and oxidative stress. Mechanistically, BaP activated the NF-κB/TNF-α signaling axis, upregulating ICAM-1 and initiating NLRP3 inflammasome assembly. Activated NLRP3 promoted Caspase-1-dependent cleavage of GSDMD, leading to hepatocyte pyroptosis and the release of IL-1β and IL-18. Concurrently, ICAM-1 facilitated inflammatory cell infiltration. This sustained inflammatory microenvironment ultimately activated the TGF-β/α-SMA/Col-I axis, driving hepatic stellate cell activation and excessive extracellular matrix deposition, thereby promoting liver fibrosis. Our findings elucidate a cascading pathway linking BaP exposure to oxidative stress, NLRP3-mediated pyroptosis, and hepatic fibrogenesis.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.